Raymond James Maintains Outperform on DexCom, Raises Price Target to $189

Raymond James maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $172 to $189.

Benzinga · 11/07/2019 17:29

Raymond James maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $172 to $189.